Lyka Labs Ltd.

73.622%

2026-08-21

lykalabs.comBSE: 500259NSE: LYKALABS
Market Cap₹ 255 Cr.
Current Price₹ 72
High / Low₹ 103 / 44
Stock P/E0.0
Book Value₹ 25
Price to Book1.85
Dividend Yield0.00 %
ROCE-20.3 %
ROE-31.1 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2023 • Formulations: 96.3% • Bulk Drugs: 3.7%

PROS

  • Working capital cycle has improved - days down from 68 to 21

CONS

  • Company is loss-making at the operating / net level
  • Recent results are weak - TTM profit is down 735.8% versus prior year
  • Company has a low return on equity of -8.9% over last 3 years
  • Company has a low return on capital employed of -3.1%
  • Interest coverage is weak at -9.0x - earnings barely cover interest
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.25x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.359020.001555.0530800.001178.0121.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.11362.07123.942026.3129.1018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.LYKALABS70.610.00255.270.002.05105.5242.3128.09-5.9610.75
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
21
19
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
-2
Tax %
-2.38%
Net Profit
-2
-1
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
27
23
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
-0
Tax %
34.09%
Net Profit
-0
-0
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
31
26
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
3
2
Tax %
43.33%
Net Profit
1
0
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
27
25
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
-1
Tax %
-33.88%
Net Profit
-2
-0
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
33
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
30
26
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
2
Tax %
25.53%
Net Profit
2
0
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
41
36
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
2
3
Tax %
24.46%
Net Profit
2
1
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
33
28
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
4
Tax %
24.79%
Net Profit
3
1
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
31
27
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
1
2
Tax %
43.58%
Net Profit
1
0
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
29
26
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
1
Tax %
30.77%
Net Profit
1
0
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
33
36
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
-5
Tax %
24.38%
Net Profit
-4
-1
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
31
29
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
0
Tax %
0.00%
Net Profit
0
0
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
28
33
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
2
-30
Tax %
0.43%
Net Profit
-30
-8
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
42
41
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
2
2
Tax %
-5.37%
Net Profit
2
0
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
36
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
78
56
Operating Profit
23
OPM %
30
Other Income
2
Interest
17
Depreciation
6
-1
Tax %
67
Net Profit
-0
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-0
Mar 2018
42
42
Operating Profit
1
OPM %
3
Other Income
2
Interest
8
Depreciation
6
-11
Tax %
3
Net Profit
-11
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-4
Minority Interest
0
Share of Associates
0
Adjusted EPS
-4
Mar 2019
41
40
Operating Profit
4
OPM %
9
Other Income
3
Interest
6
Depreciation
4
-7
Tax %
124
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2020
41
44
Operating Profit
-1
OPM %
-2
Other Income
3
Interest
19
Depreciation
8
-55
Tax %
-0
Net Profit
-55
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-19
Minority Interest
0
Share of Associates
0
Adjusted EPS
-19
Mar 2021
62
48
Operating Profit
17
OPM %
27
Other Income
2
Interest
26
Depreciation
8
-18
Tax %
21
Net Profit
-14
EPS
-5
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-5
Minority Interest
0
Share of Associates
0
Adjusted EPS
-5
Mar 2022
164
67
Operating Profit
100
OPM %
61
Other Income
3
Interest
20
Depreciation
15
60
Tax %
34
Net Profit
40
EPS
14
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Mar 2023
81
65
Operating Profit
19
OPM %
24
Other Income
3
Interest
12
Depreciation
14
-13
Tax %
-1
Net Profit
-13
EPS
-5
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-4
Minority Interest
0
Share of Associates
0
Adjusted EPS
-4
Mar 2024
106
92
Operating Profit
16
OPM %
15
Other Income
2
Interest
5
Depreciation
12
-1
Tax %
-143
Net Profit
-2
EPS
-1
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-1
Minority Interest
0
Share of Associates
0
Adjusted EPS
-1
Mar 2025
135
117
Operating Profit
20
OPM %
15
Other Income
3
Interest
2
Depreciation
7
11
Tax %
29
Net Profit
8
EPS
2
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2026
121
123
Operating Profit
2
OPM %
1
Other Income
4
Interest
3
Depreciation
8
-33
Tax %
3
Net Profit
-32
EPS
-9
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-9
Minority Interest
0
Share of Associates
0
Adjusted EPS
-9
TTM
134
138
Operating Profit
OPM %
Other Income
3
Interest
3
Depreciation
8
-32
Tax %
4
Net Profit
-31
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
8%
5 Years:
14%
3 Years:
14%

COMPOUNDED PROFIT GROWTH

10 Years:
5 Years:
3 Years:

STOCK PRICE CAGR

10 Years:
1%
5 Years:
0%
3 Years:
-15%
1 Year:
-28%

RETURN ON EQUITY

10 Years:
-12%
5 Years:
22%
3 Years:
-9%
Last Year:
-31%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

No bonus data found

Mar 2017
Equity Capital
22
52
38
Trade Payables
28
102
Total Liabilities
242
86
Capital Work in Progress
17
62
9
0
Cash & Bank
1
66
Total Assets
242
Total Debt
113
Net Working Capital
-84
Contingent Liabilities
69
Book Value per Share
33.40
Face Value
10.00
Total Debt
113
Net Working Capital
-84
Contingent Liabilities
69
Book Value per Share
33.40
Face Value
10.00
Mar 2018
Equity Capital
28
68
36
Trade Payables
21
90
Total Liabilities
243
81
Capital Work in Progress
17
62
7
0
Cash & Bank
0
75
Total Assets
243
Total Debt
102
Net Working Capital
-87
Contingent Liabilities
44
Book Value per Share
34.12
Face Value
10.00
Total Debt
102
Net Working Capital
-87
Contingent Liabilities
44
Book Value per Share
34.12
Face Value
10.00
Mar 2019
Equity Capital
28
70
12
Trade Payables
22
106
Total Liabilities
238
76
Capital Work in Progress
18
62
6
0
Cash & Bank
0
76
Total Assets
238
Total Debt
92
Net Working Capital
-19
Contingent Liabilities
55
Book Value per Share
34.77
Face Value
10.00
Total Debt
92
Net Working Capital
-19
Contingent Liabilities
55
Book Value per Share
34.77
Face Value
10.00
Mar 2020
Equity Capital
29
-10
11
Trade Payables
17
163
Total Liabilities
209
102
Capital Work in Progress
17
32
6
0
Cash & Bank
8
44
Total Assets
209
Total Debt
137
Net Working Capital
-25
Contingent Liabilities
39
Book Value per Share
6.55
Face Value
10.00
Total Debt
137
Net Working Capital
-25
Contingent Liabilities
39
Book Value per Share
6.55
Face Value
10.00
Mar 2021
Equity Capital
29
-24
10
Trade Payables
12
171
Total Liabilities
197
95
Capital Work in Progress
16
32
4
0
Cash & Bank
7
42
Total Assets
197
Total Debt
162
Net Working Capital
-20
Contingent Liabilities
41
Book Value per Share
1.54
Face Value
10.00
Total Debt
162
Net Working Capital
-20
Contingent Liabilities
41
Book Value per Share
1.54
Face Value
10.00
Mar 2022
Equity Capital
29
16
20
Trade Payables
9
135
Total Liabilities
209
90
Capital Work in Progress
16
32
8
0
Cash & Bank
15
46
Total Assets
209
Total Debt
129
Net Working Capital
-46
Contingent Liabilities
43
Book Value per Share
15.49
Face Value
10.00
Total Debt
129
Net Working Capital
-46
Contingent Liabilities
43
Book Value per Share
15.49
Face Value
10.00
Mar 2023
Equity Capital
31
28
8
Trade Payables
8
104
Total Liabilities
179
66
Capital Work in Progress
15
32
7
0
Cash & Bank
9
50
Total Assets
179
Total Debt
72
Net Working Capital
12
Contingent Liabilities
34
Book Value per Share
19.22
Face Value
10.00
Total Debt
72
Net Working Capital
12
Contingent Liabilities
34
Book Value per Share
19.22
Face Value
10.00
Mar 2024
Equity Capital
33
57
12
Trade Payables
11
73
Total Liabilities
186
56
Capital Work in Progress
22
32
10
26
Cash & Bank
6
35
Total Assets
186
Total Debt
57
Net Working Capital
14
Contingent Liabilities
32
Book Value per Share
27.28
Face Value
10.00
Total Debt
57
Net Working Capital
14
Contingent Liabilities
32
Book Value per Share
27.28
Face Value
10.00
Mar 2025
Equity Capital
36
85
15
Trade Payables
14
43
Total Liabilities
193
85
Capital Work in Progress
0
15
12
40
Cash & Bank
1
38
Total Assets
193
Total Debt
38
Net Working Capital
25
Contingent Liabilities
27
Book Value per Share
33.94
Face Value
10.00
Total Debt
38
Net Working Capital
25
Contingent Liabilities
27
Book Value per Share
33.94
Face Value
10.00
Mar 2026
Equity Capital
36
51
19
Trade Payables
17
48
Total Liabilities
171
87
Capital Work in Progress
2
0
14
33
Cash & Bank
1
34
Total Assets
171
Total Debt
48
Net Working Capital
7
Contingent Liabilities
34
Book Value per Share
24.25
Face Value
10.00
Total Debt
48
Net Working Capital
7
Contingent Liabilities
34
Book Value per Share
24.25
Face Value
10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
20
Cash from Investing
-5
Cash from Financing
-15
-0
Free Cash Flow
20
OCF / Net Profit
-108.24
Cumulative 5-Year FCF
0
OCF / Net Profit
-108.24
Cumulative 5-Year FCF
0
Mar 2018
7
Cash from Investing
-3
Cash from Financing
-4
-1
Free Cash Flow
5
OCF / Net Profit
-0.63
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.63
Cumulative 5-Year FCF
0
Mar 2019
18
Cash from Investing
-3
Cash from Financing
-16
-0
Free Cash Flow
18
OCF / Net Profit
10.57
Cumulative 5-Year FCF
0
OCF / Net Profit
10.57
Cumulative 5-Year FCF
0
Mar 2020
-11
Cash from Investing
0
Cash from Financing
20
8
Free Cash Flow
-58
OCF / Net Profit
0.21
Cumulative 5-Year FCF
0
OCF / Net Profit
0.21
Cumulative 5-Year FCF
0
Mar 2021
6
Cash from Investing
0
Cash from Financing
-8
-2
Free Cash Flow
-16
OCF / Net Profit
-0.40
Cumulative 5-Year FCF
-30
OCF / Net Profit
-0.40
Cumulative 5-Year FCF
-30
Mar 2022
77
Cash from Investing
-4
Cash from Financing
-63
9
Free Cash Flow
68
OCF / Net Profit
1.92
Cumulative 5-Year FCF
17
OCF / Net Profit
1.92
Cumulative 5-Year FCF
17
Mar 2023
7
Cash from Investing
7
Cash from Financing
-20
-7
Free Cash Flow
7
OCF / Net Profit
-0.52
Cumulative 5-Year FCF
19
OCF / Net Profit
-0.52
Cumulative 5-Year FCF
19
Mar 2024
3
Cash from Investing
-9
Cash from Financing
3
-3
Free Cash Flow
-4
OCF / Net Profit
-1.36
Cumulative 5-Year FCF
-3
OCF / Net Profit
-1.36
Cumulative 5-Year FCF
-3
Mar 2025
-2
Cash from Investing
-11
Cash from Financing
8
-5
Free Cash Flow
-17
OCF / Net Profit
-0.20
Cumulative 5-Year FCF
37
OCF / Net Profit
-0.20
Cumulative 5-Year FCF
37
Mar 2026
5
Cash from Investing
-9
Cash from Financing
4
-0
Free Cash Flow
-7
OCF / Net Profit
-0.16
Cumulative 5-Year FCF
46
OCF / Net Profit
-0.16
Cumulative 5-Year FCF
46

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
EPS (₹)
-0.08
Book Value (₹)
33.40
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.42
Operating Margin %
27.54%
Net Margin %
-0.22%
ROE %
-0.27%
ROCE %
9.01%
-0.08%
Debtor Days
108
Inventory Days
35
Payable Days
293
-150
Debt to Equity (x)
1.53x
Interest Coverage (x)
0.97x
0.36x
Revenue Growth %
36.21%
Operating Profit Growth %
20.16%
Net Profit Growth %
-103.86%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
-3.85
Book Value (₹)
34.12
Dividend per Share (₹)
0.00
Cash EPS (₹)
-1.61
Operating Margin %
3.24%
Net Margin %
-25.51%
ROE %
-12.78%
ROCE %
-1.80%
-4.47%
Debtor Days
234
Inventory Days
71
Payable Days
419
-114
Debt to Equity (x)
1.06x
Interest Coverage (x)
-0.45x
0.38x
Revenue Growth %
-46.57%
Operating Profit Growth %
-94.14%
Net Profit Growth %
-5718.25%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
0.62
Book Value (₹)
34.77
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.19
Operating Margin %
8.68%
Net Margin %
4.21%
ROE %
1.79%
ROCE %
-0.70%
0.72%
Debtor Days
266
Inventory Days
59
Payable Days
356
-32
Debt to Equity (x)
0.94x
Interest Coverage (x)
-0.24x
0.72x
Revenue Growth %
-1.20%
Operating Profit Growth %
160.06%
Net Profit Growth %
115.99%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
-19.31
Book Value (₹)
6.55
Dividend per Share (₹)
0.00
Cash EPS (₹)
-16.60
Operating Margin %
-1.52%
Net Margin %
-135.94%
ROE %
-94.98%
ROCE %
-20.89%
-24.76%
Debtor Days
162
Inventory Days
52
Payable Days
359
-144
Debt to Equity (x)
7.29x
Interest Coverage (x)
-1.90x
0.55x
Revenue Growth %
-1.07%
Operating Profit Growth %
-117.32%
Net Profit Growth %
-3295.99%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
-5.04
Book Value (₹)
1.54
Dividend per Share (₹)
0.00
Cash EPS (₹)
-2.23
Operating Margin %
26.72%
Net Margin %
-23.22%
ROE %
-124.71%
ROCE %
4.45%
-7.12%
Debtor Days
48
Inventory Days
29
Payable Days
221
-144
Debt to Equity (x)
36.68x
Interest Coverage (x)
0.28x
0.57x
Revenue Growth %
52.82%
Operating Profit Growth %
2785.81%
Net Profit Growth %
73.89%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
13.91
Book Value (₹)
15.49
Dividend per Share (₹)
0.00
Cash EPS (₹)
19.27
Operating Margin %
60.98%
Net Margin %
24.28%
ROE %
163.37%
ROCE %
47.25%
19.67%
Debtor Days
31
Inventory Days
14
Payable Days
122
-78
Debt to Equity (x)
2.90x
Interest Coverage (x)
4.02x
0.50x
Revenue Growth %
163.96%
Operating Profit Growth %
502.43%
Net Profit Growth %
375.97%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
-4.33
Book Value (₹)
19.22
Dividend per Share (₹)
0.00
Cash EPS (₹)
0.07
Operating Margin %
23.64%
Net Margin %
-16.49%
ROE %
-25.69%
ROCE %
-1.02%
-6.86%
Debtor Days
79
Inventory Days
34
Payable Days
106
7
Debt to Equity (x)
1.21x
Interest Coverage (x)
-0.14x
1.41x
Revenue Growth %
-50.96%
Operating Profit Growth %
-80.99%
Net Profit Growth %
-133.30%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
-0.69
Book Value (₹)
27.28
Dividend per Share (₹)
0.00
Cash EPS (₹)
3.03
Operating Margin %
13.69%
Net Margin %
-2.13%
ROE %
-3.04%
ROCE %
2.54%
-1.24%
Debtor Days
74
Inventory Days
28
Payable Days
81
21
Debt to Equity (x)
0.63x
Interest Coverage (x)
0.81x
1.39x
Revenue Growth %
32.02%
Operating Profit Growth %
-14.93%
Net Profit Growth %
82.92%
84.16%
P/E (x)
0.00x
P/B (x)
3.88x
Dividend Yield %
0.00%
24.77x
Mar 2025
EPS (₹)
2.22
Book Value (₹)
33.94
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.11
Operating Margin %
12.93%
Net Margin %
5.88%
ROE %
7.49%
ROCE %
8.50%
4.18%
Debtor Days
90
Inventory Days
30
Payable Days
85
35
Debt to Equity (x)
0.31x
Interest Coverage (x)
5.82x
1.56x
Revenue Growth %
26.60%
Operating Profit Growth %
24.46%
Net Profit Growth %
448.97%
423.55%
P/E (x)
45.50x
P/B (x)
2.97x
Dividend Yield %
0.00%
19.68x
Mar 2026
EPS (₹)
-9.05
Book Value (₹)
24.25
Dividend per Share (₹)
0.00
Cash EPS (₹)
-6.68
Operating Margin %
-1.99%
Net Margin %
-26.71%
ROE %
-31.09%
ROCE %
-20.28%
-17.77%
Debtor Days
111
Inventory Days
39
Payable Days
123
27
Debt to Equity (x)
0.56x
Interest Coverage (x)
-8.99x
1.13x
Revenue Growth %
-10.24%
Operating Profit Growth %
-92.24%
Net Profit Growth %
-507.78%
-507.78%
P/E (x)
0.00x
P/B (x)
1.85x
Dividend Yield %
0.00%
132.12x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
58.10
0.15
0.75
Government
0.00
40.99
Sep 2024
58.10
0.15
0.66
Government
0.00
41.08
Dec 2024
58.10
0.15
0.66
Government
0.00
41.07
Mar 2025
58.16
0.24
0.66
Government
0.00
40.94
Jun 2025
58.16
0.16
0.66
Government
0.00
41.01
Sep 2025
58.16
0.17
0.66
Government
0.00
41.00
Dec 2025
58.16
0.17
0.66
Government
0.00
41.00
Mar 2026
58.16
0.29
0.66
Government
0.00
40.88
Jun 2026
58.45
0.17
0.66
Government
0.00
40.72

Documents

Announcements

  • Copy of Newspaper Publication

    2026-08-12 - Lyka Labs Limited has informed the Exchange about Copy of Newspaper Publication

  • Shareholders meeting

    2026-08-11 - Lyka Labs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 10, 2026. Further, the company has informed the Exchange regarding voting results.

Credit Ratings

  • Credit Rating

    2026-04-30 - Lyka Labs Limited has informed the Exchange about Credit Rating

Concalls

Nothing filed yet.